By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Novo Nordisk A/S 

Novo Allé

Bagsvaerd    2880  Denmark
Phone: 45-4444-8888 Fax: 45-4449-0555


SEARCH JOBS


Industry
Big Pharma


Collaborations

CelTor Biosystems, Inc.  Research collaboration

Aradigm Corporation  Commercial agreement to develop AERx technology for the delivery of insulin, insulin analogues and other glucose-lowering agents for diabetes management.

Incyte Corporation 

Maxygen, Inc. 

Intergen Company 





Company News
European Medicines Agency Release: Novo Nordisk A/S (NVO)'s Saxenda Recommended For Approval In Weight Management In Adults 1/23/2015 9:22:26 AM
Novo Nordisk A/S (NVO) Plans to Use 500 Sales Reps to Promote New Obesity Drug 12/30/2014 6:28:57 AM
Novo Nordisk A/S (NVO) Already Seeking Successor for CEO That Will Most Likely Step Down in 2019 12/29/2014 6:16:30 AM
Novo Nordisk A/S (NVO) Receives FDA Approval For Saxenda® For The Treatment Of Obesity 12/24/2014 6:07:42 AM
SoCal's Xencor Snags $175 Million+ R&D Pact With Novo Nordisk A/S (NVO) 12/18/2014 6:13:06 AM
Novo Nordisk A/S (NVO) And Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement For Verizon Indycar Series 12/12/2014 8:08:36 AM
Novo Nordisk A/S (NVO) Release: Novoeight Phase 3 Data Show Reduction In Annualised Bleeding Rate Over Time In People With Haemophilia A 12/8/2014 7:45:24 AM
Novo Nordisk A/S (NVO) To Present Hemophilia Portfolio And Pipeline Data At 56th American Society of Hematology Meeting 12/1/2014 4:01:03 PM
Novo Nordisk A/S (NVO) Restructures Executive Board As Chief Of Staff Leaves 11/26/2014 6:27:04 AM
Amneal Pharmaceuticals Launches AG For Novo Nordisk A/S (NVO)’s Activella® 11/20/2014 11:13:28 AM
12345678910...
//-->